Shown: posts 1 to 9 of 9. This is the beginning of the thread.
Posted by Chris A. on March 24, 2000, at 0:44:10
Does anyone know if ziprasidone has been, or is going to be released on the US market?
Thanks,
Chris A.
Posted by Cam W. on March 24, 2000, at 6:18:42
In reply to Ziprasidone, posted by Chris A. on March 24, 2000, at 0:44:10
Chris - At a lecture I had recently attended, the presenter, Dr.R.Petty (same guy who said schizophrenia & bipolar where the same disorder), also said that Ziprasidone will not be released (in U.S. or Canada) due to some heart problems that it causes. I have not talked to the Pfizer rep lately, though, so I don't know the real status. - Cam W.
Posted by Noa on March 24, 2000, at 9:02:16
In reply to Re: Ziprasidone, posted by Cam W. on March 24, 2000, at 6:18:42
what is it?
Posted by Chris A. on March 24, 2000, at 10:25:33
In reply to Re: Ziprasidone, posted by Noa on March 24, 2000, at 9:02:16
Thanks for the info., Cam. It's a neuroleptic. My consultant had it on the list of treatments for me to try, but it's been eight months since I saw him. Zeldox must have been the trade name.
Chris A.
Posted by Cam W. on March 24, 2000, at 21:13:48
In reply to Re: Ziprasidone, posted by Chris A. on March 24, 2000, at 10:25:33
Noa - Zeldox (ziprasidone) is another atypical antipsychotic. It can cause heart problems, so it may not make it to market in the U.S. and Canada. I think it is believed not to cause the weight gain of Zyprexa or the EPS and prolactin increases of Risperidone, while maintaining the efficacy of these agents. I would like to see it used in clinical practice before making any definitive claims on it though, and it looks like I may not be able to do that any time soon (sigh). Hope this helps - Cam W.
Posted by ChrisK on March 25, 2000, at 6:10:43
In reply to Re: Ziprasidone - Noa, posted by Cam W. on March 24, 2000, at 21:13:48
Cam,
My doctor seemed to think that Zeldox was on track to be relesed this year. I have searched the Pfizer website for mention of it and the only ones were in the 1998 Annual report. In several places they said that they would be submitting it to the FDA in 1999.
Do you know if it was ever submitted? Or were the heart problems found in their own studies and thus not submitted for approval?
When your Pfizer rep comes to visit will you please ask him where it stands? I like my Zyprexa but the weight thing is really a pain and I'm not sure about the long term use and its overall longterm effects.
Thanks,
Chris>
> Noa - Zeldox (ziprasidone) is another atypical antipsychotic. It can cause heart problems, so it may not make it to market in the U.S. and Canada. I think it is believed not to cause the weight gain of Zyprexa or the EPS and prolactin increases of Risperidone, while maintaining the efficacy of these agents. I would like to see it used in clinical practice before making any definitive claims on it though, and it looks like I may not be able to do that any time soon (sigh). Hope this helps - Cam W.
Posted by Robert Trudell on September 29, 2000, at 17:48:18
In reply to Ziprasidone, posted by Chris A. on March 24, 2000, at 0:44:10
On July 20, 2000 FDA Committee Recommends Approval For Zeldox:
http://www.pslgroup.com/dg/1da2ba.htm
> Does anyone know if ziprasidone has been, or is going to be released on the US market?
>
> Thanks,
>
> Chris A.
Posted by Josie on November 10, 2000, at 21:42:13
In reply to Cam W. Question, posted by ChrisK on March 25, 2000, at 6:10:43
The Advisory Committee to the FDA recommended approval of Zeldox/Ziprasidone in July, 2000.
Posted by Cam W. on November 11, 2000, at 11:03:53
In reply to Re: Cam W. Question, posted by Josie on November 10, 2000, at 21:42:13
> The Advisory Committee to the FDA recommended approval of Zeldox/Ziprasidone in July, 2000.
Josie - Thank you. - Cam
This is the end of the thread.
Psycho-Babble Medication | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.